LGALS9 and lung carcinoma: Both studies, conducted in different lung cancer types, showed a significant association between Gal-9 and TIME and immune infiltration in lung cancer, particularly in stage I-III SCLC and LCNEC, where Gal-9 exhibited unique prognostic value.